Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial
Salah‐Eddin Al‐Batran(Goethe University Frankfurt), Andrea Tannapfel(Leipzig University), Alexander Reichart(Goethe University Frankfurt), Dirk Behringer(Augusta-Kranken-Anstalt), Claudia Pauligk(Goethe University Frankfurt), Nils Homann(Fraunhofer Project Centre Wolfsburg), Alfred Königsrainer(American Institute of Biological Sciences), Gerald Illerhaus(Klinikum Stuttgart), Uwe M. Martens(Memorial Sloan Kettering Cancer Center), Stephan Probst(Klinikum Bielefeld), Georg Martin Haag(Heidelberg University), Ulrich Ronellenfitsch(University of Mannheim), Michael Pohl, Stefan Mönig(Hôpital Beau-Séjour), Hans‐Georg Kopp(Robert Bosch Hospital), Martin Schüler(German Cancer Research Center), Wolf O. Bechstein(Unknown), Nicole Prasnikar(Asklepios Klinik Barmbek), Rolf Mahlberg(Klinikum Mutterhaus der Borromäerinnen), Mark Sievert(Sanofi (Germany)), Andreas Block(Universität Hamburg), Wael Hozaeel(Marienhospital Stuttgart), Ralf‐Dieter Hofheinz(University of Mannheim), Kim Barbara Luley(University Hospital Schleswig-Holstein), Elke Jäger(Krankenhaus Nordwest), Katja Zirlik(University Medical Center Freiburg), Harald Schmalenberg(Heidelberg University), Michael Heike(Klinikum Dortmund), Thorsten Oliver Goetze(Institute of Clinical Cancer Research), Matthias Egger(University of Zurich), Peter Schirmacher(Heidelberg University), Wolff Schmiegel(Universitätsklinikum Knappschaftskrankenhaus Bochum), Jörg Trojan(Goethe University Frankfurt), Michael Koenigsmann, Karel Caca(Klinikum Ludwigsburg), Michael Clemens(Klinikum Mutterhaus der Borromäerinnen), Sylvie Lorenzen(Technical University of Munich), Wolfgang Fischbach(Klinikum Aschaffenburg), Timo Gaiser(University of Mannheim)
Cited by 738
Related Papers
Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis
|The Lancet|2018|3.5k
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations
|Journal of Clinical Oncology|2013|3.2k
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
|The Lancet|2008|1.9k
Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation
|New England Journal of Medicine|2021|1.8k